Accumulating evidence has shown that α-Syn is a target of TG2 transamidation activity in vitro and in vivo [30,143,144,145,146], implicating TG2 activity in α-Syn aggregation and the pathogenesis of synucleinopathies (Figure 2g). Here, TGM2 is linked to synucleinopathy.